Regenxbio (RGNX) Return on Sales (2014 - 2025)
Regenxbio (RGNX) recorded quarterly Return on Sales of 0.02% in Q4 2025, down 6.25% quarter-over-quarter from 0.02% in Q3 2025, and little changed on a YoY basis from 0.02% in Q4 2024.
Regenxbio (RGNX) Return on Sales (2014 - 2025) Analysis & Trends
Regenxbio's Return on Sales history runs 12 years deep, the most recent figure standing at 0.02% for Q4 2025.
- In Q4 2025, Return on Sales changed 0.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.01% (up 2.0% YoY), while the FY2025 annual figure was 0.01%, up 2.0% from the prior year.
- Return on Sales was 0.02% for Q4 2025 at Regenxbio, down from 0.02% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.07% in Q4 2022 to a low of 0.04% in Q1 2024.
- Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.02% in 2024.
- The sharpest annual moves came in 2022 and 2023: Return on Sales rose 6 bps in 2022, then decreased 10 bps in 2023.
- A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then soared by 853 bps to 0.07% in 2022, then slumped by 140 bps to 0.03% in 2023, then climbed by 15 bps to 0.02% in 2024, then gained by 8 bps to 0.02% in 2025.
- The last three Return on Sales figures came in at 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.03% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | 0.07% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | -0.02% |
| Jun 30, 2021 | -0.03% |
| Mar 31, 2021 | -0.03% |